Tourmaline Bio Quote - TRML

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

17.54

Bid

16.13

Ask

19.96

Volume

254,558

17.205 Day's Range 17.68

12.12 52 Week Range 48.31

Market Cap

449.771M

Previous Close

17.51

Open

17.39

Last Trade

17.98

Last Trade Time

Financial Volume

US$ 4,454,603

VWAP

17.4994

Average Volume (3m)

203,999

Shares Outstanding

25,642,610

Dividend Yield

PE Ratio

-10.67

Earnings Per Share (EPS)

-1.64

Revenue

Net Profit

-42.12M

Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and ... Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

talaristx.com

Headquarters

Wilmington, Delaware, USA

Founded

Tourmaline Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TRML. The last closing price for Tourmaline Bio was US$17.51. Over the last year, Tourmaline Bio shares have traded in a share price range of US$ 12.12 to US$ 48.31.

Tourmaline Bio currently has 25,642,610 shares outstanding. The market capitalization of Tourmaline Bio is US$449 million. Tourmaline Bio has a price to earnings ratio (PE ratio) of -10.67.

Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker

NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...

Form 8-K - Current report

Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day

– Phase 2 TRANQUILITY trial surpasses enrollment target, with 143 total patients enrolled; topline data expected in second quarter of 2025 – – Deepak L. Bhatt, MD, MPH, MBA and Dipender Gill, MD...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	17.54	18.79	17.48	222224	17.8773776	CS
4	-4.37	-19.9452304884	21.91	22.21	17	197857	19.14684955	CS
12	-8.37	-32.3041296797	25.91	29.6461	17	203999	22.64691449	CS
26	2.08	13.4540750323	15.46	29.7883	13.03	200314	22.44650935	CS
52	-21.76	-55.368956743	39.3	48.31	12.12	279191	23.00300545	CS
156	7.22	69.9612403101	10.32	48.31	9.18	247328	22.9248675	CS
260	7.22	69.9612403101	10.32	48.31	9.18	247328	22.9248675	CS

TRML - Frequently Asked Questions (FAQ)

What is the current Tourmaline Bio share price?

The current share price of Tourmaline Bio is US$ 17.54

How many Tourmaline Bio shares are in issue?

Tourmaline Bio has 25,642,610 shares in issue

What is the market cap of Tourmaline Bio?

The market capitalisation of Tourmaline Bio is USD 449M

What is the 1 year trading range for Tourmaline Bio share price?

Tourmaline Bio has traded in the range of US$ 12.12 to US$ 48.31 during the past year

What is the PE ratio of Tourmaline Bio?

The price to earnings ratio of Tourmaline Bio is -10.67

What is the reporting currency for Tourmaline Bio?

Tourmaline Bio reports financial results in USD

What is the latest annual profit for Tourmaline Bio?

The latest annual profit of Tourmaline Bio is USD -42.12M

What is the registered address of Tourmaline Bio?

The registered address for Tourmaline Bio is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Tourmaline Bio website address?

The website address for Tourmaline Bio is talaristx.com

Which industry sector does Tourmaline Bio operate in?

Tourmaline Bio operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
EVAXEvaxion Biotech AS	US$ 5.99 (64.56%)	55.41M
ELABPMGC Holdings Inc	US$ 3.0901 (56.07%)	76.48M
PCLAPicoCELA Inc	US$ 4.60 (49.35%)	3.75M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
GODNUGolden Star Acquisition Corporation	US$ 3.11 (-75.82%)	17.51k
GODNGolden Star Acquisition Corporation	US$ 2.93 (-65.67%)	902.76k
NXTTNext Technology Holding Inc	US$ 1.37 (-54.93%)	2.56M
SGLYSingularity Future Technology Ltd	US$ 1.625 (-38.45%)	917.77k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 90.11 (-38.07%)	8
ACONAclarion Inc	US$ 0.0557 (28.94%)	811.91M
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
RIMEAlgorhythm Holdings Inc	US$ 0.0357 (4.69%)	284.97M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
NVDANVIDIA Corporation	US$ 142.62 (-3.12%)	232.88M